Allurion Technologies Inc
allurion.comWhat Do They Do?
Sells a swallowable gastric balloon and provides virtual care tools for weight-loss patients and their health care providers.
10-K for FY2025, filed Mar 30, 2026Our company is pioneering metabolically healthy weight loss by creating a best-in-class weight loss platform to treat the estimated two…View ↗
For Allurion Program patients: Every current Allurion Program patient receives an Allurion Connected Scale (“Allurion Connected Scale”) and…View ↗
For Allurion Program providers: Every Allurion Program provider receives access to our clinic dashboard - Allurion Insights. Allurion…View ↗
How Do They Make Money?
It sells the Allurion Smart Capsule and accessories to distributors and health care providers; sales are counted when the products ship.
10-K for FY2025, filed Mar 30, 2026The Company generates revenue from sales of its Allurion Smart Capsule to distributors and health care providers. Customers typically…View ↗
$15.2M
-
10-K for FY2025, filed Mar 30, 2026
$15.2M ↗
Who Are Their Customers?
Health care providers and distributors buy the Smart Capsule. Allurion sells directly through its sales force in some countries and through distributors in others.
10-K for FY2025, filed Mar 30, 2026The Company generates revenue from sales of its Allurion Smart Capsule to distributors and health care providers. Customers typically…View ↗
To date, most of our revenues have been generated from sales of the Allurion Smart Capsule. We began selling the Allurion Smart Capsule in…View ↗
We currently sell our products either through our direct sales force, or in certain countries, through distributors. As of December 31…View ↗
Do Revenues Turn Into Profits?
No. It lost $28.8M in FY2025.
10-K for FY2025, filed Mar 30, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q1 FY2026, filed May 15, 2026
−$6.1MView ↗
- ▲ +306% (Loss)
- vs −$1.5M in Q1 FY2025
-
Jul 23, 2026
Chief executive officer resigns
The board had not named an interim or permanent successor; the chief operating officer will oversee day-to-day operations.
Sources
8-K, filed Jul 23, 2026
On July 17, 2026, Shantanu K. Gaur, M.D. notified Allurion Technologies, Inc. (the “Company”) of his resignation as Chief Executive Officer…View ↗
-
May 27, 2026
Company replaces its independent auditor
CBIZ was appointed auditor for fiscal 2026 after Deloitte's dismissal.
Sources
8-K, filed May 27, 2026
Deloitte & Touche LLP (“Deloitte”) has served as the independent registered public accounting firm for Allurion Technologies, Inc. (the…View ↗
Who Do They Compete With?
Competes with SC MedSil, Medicone, Spatz Laboratories, Boston Scientific, Medtimo, Spatz FGIA, Novo Nordisk, Eli Lilly, Roche Holding, GlaxoSmithKline, Arena Pharmaceuticals, VIVUS, and Orexigen Therapeutics
10-K for FY2025, filed Mar 30, 2026We have developed, manufactured, and commercialized the world’s first and only swallowable, ProcedurelessTM gastric balloon for weight…View ↗
Loading...
